chrisvoncsefalvay/vaers-outcomes huggingface dataset:
herpes zoster; Information was received from a lawyer regarding a case in litigation concerning a female patient (pt) of unknown age. The pt's medical history, concurrent conditions, or concomitant medication were not provided. In or around 28-FEB-2014, the pt was inoculated with zoster vaccine live (ZOSTAVAX) (dose, frequency, route of administration, anatomical location, lot number and expiration date were not provided) for routine health maintenance and for its intended purpose: the prevention of shingles (herpes zoster). Shortly after vaccination, the pt suffered reoccurring rashes on her buttocks, face and chest; and was diagnosed with herpes zoster. As a direct and proximate result of the company's defective zoster vaccine live (ZOSTAVAX), the pt's symptoms resulted in physical limitations not present prior to using the vaccine. The pt also experienced mental and emotional distress due to resulting physical limitations and seriousness of her condition. As a result of the manufacture, marketing, advertising, promotion, distribution and/or sale of zoster vaccine live (ZOSTAVAX), the pt sustained severe and permanent personal injuries. Further, as a tragic consequence of the company's wrongful conduct, the pt suffered serious, progressive, permanent, and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. As a direct and proximate result, the pt suffered and incurred damages, including medical expenses; the loss of accumulations; and other economic and non-economic damages. The outcome of herpes zoster was reported as not resolved. The causal relationship of herpes zoster was reported as related to zoster vaccine live (ZOSTAVAX). The reporter considered herpes zoster to be a disabling event.
Patient reports cluster headaches after getting the vaccine last year.  He reports the vaccine trigger his "most severe" cluster headaches after getting the anthrax vaccine.  7th January 2003 --- 1st Vaccination with the anthrax vaccine.   He reports two days after the injection that he started having cluster headaches.  With the headaches he started having vomiting.  These headaches seemed to increase in intensity at night --- had home oxygen and was treating them at home.  He reports the headaches were waking him up at night and they would be there in the morning.  The vomiting stopped after that first day of the headaches.  He reports unable to work for about 10 days.  He reports that he was continuing to have headaches all the way until he had his next vaccine.  21st January 2003 --- 2nd Vaccination.  He reports 1-2 days after the second injection he felt pretty well.  Then the third day after injection he had acute onset of his headaches.  He was seen in emergency room and was given oxygen.  He was tried on a preventative therapy and then unable to prevent the headaches.  Vomiting one episode on the 3rd day.  Headaches were back and seemed more intense.  No able to work for approximately 4 days.  Was using imitrex and oxygen for his headaches.  He deployed and the headaches were there for approximately 3 weeks.   After 3 weeks, the headaches went away and subsided on their own.  Now he reports no cluster headaches in the last year
Pt recvd flu vax on 4NOV92 & pt exp SOB described as an asthma attack 3 hrs later;
1/7/98 CBC nl sed rate WNL ;12/7/98 seen for bilat wrist pain;arthralgias; 1/4/99-bilateral, acute wrist arthralgias; Rheumatology & WRAMC immunology consult
Extreme dyspnea on mild exertion with severe dizziness within days after vaccine.  March 2023 diagnosed Left Ventricular Hypertrophy with evidence of genetic component (no known family members have had condition) with severe mitral valve prolapse and regurgitation.
Swollen armpit on 5/21 in the morning, pain and tenderness.  Daily increasing pain, by Thursday 5/27 in the morning very difficult to lift arm above my head.  Around noon,  started experiencing a tingling/numb sensation in right wrist and hand. The numb sensation is now beginning to subside but it is still painful.
Fever, aches, chills, tremor. All described as severe or high. Lasted for several hours and resolved overnight.
not sure if might be related to vaccine.  Developed  numbness , some  redness and peeling off skin inside of bottom front of the mouth.  When rinsing with Listerine, it burns and  white  patches of skin come off.  Feel of burn like from  acidic food(lemon, orange, etc.).
ARM HURTING; FEELING TIRED; This spontaneous report received from a patient concerned a 52 year old male. The patient's height, and weight were not reported. The patient's past medical history included: cough or cold (that lingered for 2 months in December (unspecified year and date). Patient states this was before covid or vaccines came out. Patient reports it took 2 months before it went away), and concurrent conditions included: glaucoma, and anti-seizure medicine user, and other pre-existing medical conditions included: The patient had no exposure to SARS-COV2-virus prior to vaccination. The patient had no diabetes, hypertension, heart disease, autoimmune disorders and immunosuppressive disorders, and not being treated with immune-modulating or immuno-suppressive medications or received other vaccines within past 30 days, no illness at the time of vaccination, no past history of similar event, no history of allergy to vaccine, drug, or food, no pre-existing acute illness 30 days prior to vaccination, no history of hospitalization in last 30 days, and no family history of any disease (relevant to vaccination) or allergy. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 204A21A expiry: 18-FEB-2022) dose was not reported, administered on 05-MAY-2021 for covid-19 prophylaxis. Age at time of vaccination 6 decade old. Concomitant medications included zonisamide for anti-seizure, latanoprost for glaucoma, and timolol maleate for glaucoma. On an unspecified date, the patient experienced arm hurting, and feeling tired. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the arm hurting and feeling tired was not reported. This report was non-serious. This case, involving the same patient is linked to 20221057885.
May be it is a blood clot on my leg, possibly a blood clot because my legs are jammed , I can hardly walk; Cramps; May be it is a blood clot on my leg, possibly a blood clot because my legs are jammed , I can hardly walk; Stiffness; my legs are jammed; because her legs were jammed, I could hardly walk, very rare she sleep and so much pain; I don't sleep at night; Needle like pain in my muscle; This is a spontaneous report from a contactable consumer (patient). A 55-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, lot number- EW853, EWA58), via an unspecified route of administration, administered in arm left on 08Apr2021 11:00 (age at vaccination was 54 years)as DOSE 2, SINGLE and first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, lot number- EN6Z08), via an unspecified route of administration, administered in arm left on 08Mar2021 11:00 as DOSE 1, SINGLE for COVID-19 immunisation. The patient's medical history included that she was disable and memory getting worse. The patient's concomitant medication was not reported. She had no prior vaccination. The patient stated that she had cramps, needle like pain in her muscle, she did not know she suppose to go for CT scan for might be it was a blood clot on her leg, stiffness and possibly a blood clot because her legs were jammed, I could hardly walk, very rare she sleep and so much pain in Apr2021. She also stated that it was getting worse. She took tablets for her to fall asleep and to relax her muscles. She was taking Tylenol and she took another medicine for the pain. The patient underwent blood test on 08Apr2021 and result was unknown. The outcome of events was not recovered.  Follow-up attempts were completed. No further information was expected.
Booster; 4 hours after the shoot began to feel tired; light headache; low grade Fever; Flu like body ache; Flu like body ache; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Lot number: FF8899, Expiration Date: Mar2022) as dose number unknown (booster), single for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (DOSE 1, manufacturer unknown), for COVID-19 Immunization; Covid-19 vaccine (DOSE 2, manufacturer unknown), for COVID-19 Immunization. The following information was reported: IMMUNISATION (non-serious) with onset 2021, outcome "unknown", described as "Booster"; FATIGUE (non-serious) with onset 2021, outcome "recovered" (2021), described as "4 hours after the shoot began to feel tired"; HEADACHE (non-serious) with onset 2021, outcome "recovered" (2021), described as "light headache"; PYREXIA (non-serious) with onset 2021, outcome "recovered" (2021), described as "low grade Fever"; INFLUENZA LIKE ILLNESS (non-serious), PAIN (non-serious) all with onset 2021, outcome "recovered" (2021) and all described as "Flu like body ache". Relevant laboratory tests and procedures are available in the appropriate section.   Additional information: Description of event: Booster shot. 4 hours after the shoot began to feel tired by next day, light headache and low grade fever, flu like body ache. Everything lasted about 2 days. Name of Product: PFE Covid-19 Vaccine. Event took place after use of product.   No follow-up attempts are possible. No further information is expected.
Patient called 2 days after vaccination informing pharmacist her upper arm (left) was swollen, warm to touch and aching. No fever or difficult in breathing. Patient called back on 8/28 bec. she went to emerg. room bec of severe discomfort.
Client called and reported L arm "purple"  all the way down and "itching all over" with tingling of L arm.  Began approx 30-45 minutes after vaccine--took po Benadryl at work.  Was evaluated @ ER--was treated with IV solumedrol and SQ epinephrine.  States upon arrival to ER began with respiratory distress.  States MD advised avoid tetanus vaccination in future unless given in hospital or clinic.
Patient reports 4 hours after vaccine, started experiencing pain, redness, hot, and swelling at the injection site continuing down the whole upper arm. Patient also  reported her "bones" started aching from her toes all the way up. Patient started experiencing a 101F fever as well as blood pressure increased from 128/72 mmHg to 150/90 mmHg. Symptoms lasted about 5 days.
Lightheaded in the morning after the shot. Fever of 100.5 at 5:30 pm. Headache
Healthcare worker describes, approx.  8 hrs. post infection, experiencing severe left shoulder pain with difficulty raising left arm above her head, pain with movement of left arm + shoulder, symptoms lasted 72 hrs;  partially resolved with OTC pain med.
Next day: chills/fever/splitting headache/extreme nausea/racing heart. The 24 hours I was sick, my Fitbit logged in 279 zone minutes (fat burning/cardio zones) but I was in bed all day.   Normal RHR is 65-68; RHR after inoculation was 77 but trending down. 5 days post inoculation, RHR is 73.
High fever 103-104 range, screaming, limping on leg for several days; wouldn't let anyone hold for, shaking & trembling, fever would not come down w/APAP rxn lasted approx 2 hrs; no convuls;
This spontaneous prospective pregnancy report was received from a registered nurse referring to a female patient of unknown age. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 28-MAR-2017, the patient was vaccinated with a dose of M-M-R II (strength, dose, route, anatomival location, lot number and expiration date were not provided), for prophylaxis, reconstituted with sterile diluent. The patient became pregnant with last menstrual period (LMP) of 15-MAR-2017 and expected date of delivery (EDD) of 20-DEC-2017. On 10-MAY-2017, the patient reported to the clinic that she was 8 weeks pregnant and "had been approximately 2 weeks pregnant" when she received the dose of M-M-R II. The patient did not received any treatment and no adverse reactions were reported. At the time of reporting, the outcome of exposure during pregnancy was unknown. Additional information has been requested.
Received flu shot high in upper left arm. Within 2 hours, had shoulder/joint pain and couldn't move arm. Pain radiates down arm. 4 days after shot, major dizziness and vertigo.  Pain in arm is still present.
Localized reaction. Reddened approx. 1" by 3" in size on 08/15/2016. Itches. Slightly warm, firmness underlying reddened area. Recommended Benadryl (diphenhydramine) by mouth - report to MD if reaction worsens or does not go away.
Patient received first dose of Pfizer vaccine in December 2020.  He was unable to receive his second dose of Pfizer vaccine.  Nursing facility in which he now resides provides Moderna and does not have access to Pfizer.  Second dose of mRNA vaccine (Moderna) administered on 4/27/21.
Staff complaints of pain, on left hand, tingling from the injection site down to her fingers, also with numbness to her left hand.
There is some residual pain today; headache; Sore left arm within first 24 hours of injection; body pains especially in the neck and armpit area; body pains especially in the neck and armpit area; This is a spontaneous report from a non-contactable consumer or other non-HCP. A 37-years old non-pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/Lot Number: EN5318), via an unspecified route of administration in Left arm on 17Feb2021 09:30 (age at the time of vaccination 37-years-old), as a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient had no known allergies. The patient had no other vaccine in four weeks. No Other medications in two weeks. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/Lot Number: EN5318), via an unspecified route of administration in Left Arm on 26Jan2021 11:45 (age at the time of vaccination 37-years-old), as a single dose for COVID-19 immunization. On 18Feb2021 09:30, the patient experienced headache, Sore left arm within first 24 hours of injection, body pains especially in the neck and armpit area, and There is some residual pain today. No treatment received for adverse events. No covid prior vaccination. No covid tested post vaccination. The outcome of all the events were recovering.  No follow-up attempts are possible. No further information is expected.
pt presented with covid vaccination card indicating he had only received first dose monovalent Moderna vaccine given 9/23/2022, pt received second dose monovalent Moderna vaccine on 11/18/2022 at our health department.  After vaccine was given, it was discovered, that pt had also obtained a Johnson and Johnson Janssen vaccine on 7/28/2021. Pt failed to report having the J&J vaccine to HCP.
Developing rash on trunk, arms and legs. Rash not itchy, red/pink, circular shaped lesions.
pt recvd vax 25JUL95 & pt devel a rash;@ the time of report approx 1month post vax the rash persisted;No further details were provided;
Rash on both arms, stomach, back, and thighs; This is a spontaneous report from a contactable consumer (patient herself). A 25-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, (Batch/Lot Number: EN 6204)), dose 1 via an unspecified route of administration, administered in the left arm on 13Mar2021 at 10:30 as dose 1, single (age at vaccination was 25-year-old) for COVID-19 immunisation. The patient's medical history included bipolar II disorder and allergy to latex and walnuts, both from an unknown date and unknown if ongoing. Concomitant medications included lithium taken for an unspecified indication, start and stop date were not reported. On 13Mar2021 at 14:30, the patient experienced rash on both arms, stomach, back, and thighs. Appeared 4 hours after vaccine dose administered. No covid prior to vaccination and covid was not tested post vaccination. No other vaccine was received in four weeks. No treatment was received by the patient for the event. The outcome of rash on both arms, stomach, back, and thighs was not recovered.  No follow-up attempts are possible. No further information is expected.
Patient noticed a change in his moods about 6 days after the first dose.  Didn't think anything about it at first but coworkers and family members noticed his moodiness and he was easily aggravated.  He reached out to us to see if anyone else had reported these symptoms following their Moderna vaccine
FREEZING; Initial information was received on 26-Oct-2021 regarding an unsolicited valid non-serious case received from social media from consumer/non-health care professional via Medical information (under reference number - US-SA-SAC20211101001189).   This case involves a patient of (unknown demographics) who experienced freezing (feeling cold), after receiving vaccine INFLUENZA VACCINE.  The patient's medical history, past medical treatment(s), concomitant therapy, concomitant medication(s), vaccination(s) and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiry date not reported) via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed a non-serious freezing (feeling cold) (unknown latency) following the administration of INFLUENZA VACCINE.  No additional laboratory data was reported.  It was not reported if the patient received a corrective treatment for the event.  At time of reporting, the outcome was unknown for the event.  There will be no information available on batch number for this case.
Cough; Fever; Chills; Headache; Muscle pain; This spontaneous case was reported by a pharmacist and describes the occurrence of COUGH (Cough), PYREXIA (Fever), CHILLS (Chills), HEADACHE (Headache) and MYALGIA (Muscle pain) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced COUGH (Cough), PYREXIA (Fever), CHILLS (Chills), HEADACHE (Headache) and MYALGIA (Muscle pain). At the time of the report, COUGH (Cough), PYREXIA (Fever), CHILLS (Chills), HEADACHE (Headache) and MYALGIA (Muscle pain) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, COVID-19: (Negative) Negative.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) in response to the events was not applicable. Concomitant product use was not provided by the reporter. Treatment information was not provided.   This case was linked to MOD-2021-208885, MOD-2021-208885 (Patient Link).
This spontaneous report was received from a physician via a company representative, referring to a patient of unknown age and gender. The patient's concurrent conditions and medical history were not reported. On 11-JUN-2015, the patient was vaccinated with an improperly stored dose of ROTATEQ 2ml, 10 unit dose tube, lot # J010140; expiration date 26-APR-2016 (dose and dose number were not reported). There were no concomitant medications provided. No adverse effects reported. No product quality complaint was involved. On an unspecified dates, the ROTATEQ had 6 temperatures excursions of 80, 416, 24, 1172, 336 and 168 hours. The lowest recorded temperature was -3 Celsius and the highest recorded temperature was 59F (15 Celsius). The vaccine status was reported as "in excursion". The vaccine storage criteria and the vaccine excursion were reported as "Refrigerator (R)". This is one of several cases from the same reporter. Additional information has been requested.
Muscle pain in left arm, shooting pain in left arm, cannot grip with left hand, continued joint pain in left arm in shoulder, elbow and wrist with worst pain being located in elbow.
June through September 2021, had 3 episodes of disorientation lasting 20 min to 100 min.  They occurred on 3 different golf courses.  I was alert and talk coherently, I just couldn't recognize the golf courses , all of which I knew very well.  When the symptoms subsided, I recognized the courses.
1st dose of COVID vaccine Moderna administered not realizing that Moderna was not yet approved for 12 yr + up  No adverse reaction at this time
Pt with increased temperature, redness, edema at shot sites with generalized macular papular rash.
This spontaneous report as received from a physician via company representative refers to a female patient reported as "over the age of 65". Patient's concurrent conditions, medical history, information regarding drug reactions or allergies were not reported. In approximately April 2014 (reported as: "2 months ago") the patient was vaccinated with a 1 shot of ZOSTAVAX, (injection, lot#, expiration date, route of administration and anatomical location not reported). Concomitant medications were not reported. ZOSTAVAX had been administered by an unspecified pharmacist about two weeks prior to the patient presenting the symptoms to physician. About 2 weeks after ZOSTAVAX administration, in approximately 2014 (exact date not reported), the patient developed a shingles-like rash around ZOSTAVAX administration, in approximately 2014 (exact date not reported), the patient developed a shingles-like rash around ZOSTAVAX injection site. There was no treatment given for the event. Patient sought medical attention by calling physician's office. The relatedness between the event of shingles-like around the ZOSTAVAX injection site and ZOSTAVAX  was not reported. Additional information is not expected.
Information has been received from a licensed practical nurse concerning a 69 year old male with no pertinent medical history and no history of drug reactions or allergies who on 31-JAN-2008 was vaccinated with ZOSTAVAX (Oka/Merck). There was no concomitant medication. Three weeks after vaccination (on approximately 21-FEB-2008) the patient developed purple toenails. His wife told the nurse that it looked like he was hit on the toes with a hammer. The patient's purple toenails persisted. The patient did not seek medical attention and has not been seen by the doctor. Additional information has been requested. 12/23/08 This is in follow-up to report(s) previously submitted on 9/24/2008. Information has been received from a licensed practical nurse concerning a 69 year old male with hypothyroidism and no known allergies who on 31-JAN-2008 was vaccinated with a first dose of ZOSTAVAX (Oka/Merck) (lot#: 658838/1412U) SQ into the right upper arm. The patient had herpes simplex at the time of the vaccination. The patient stated he had not any fever blister since. There was no concomitant medication. Three weeks after vaccination (on approximately 21-FEB-2008) the patient developed purple toenails, 2 on one foot, and 3 on the other foot. His wife told the nurse that it looked like he was hit on the toes with a hammer. Subsequently, the patient recovered. The toenails grew out in 2 months. The patient did not seek medical attention and has not been seen by the doctor. Additional information is not expected.